Upcoming treatments for morphea
Abstract Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4–2.7 cases per 100,000. Morphea occurs most frequently in children aged 2–14 years, and the disease exhibits a female predominance. Insights in...
Saved in:
Main Authors: | Dan Wenzel, Nazgol‐Sadat Haddadi, Khashayar Afshari, Jillian M. Richmond, Mehdi Rashighi |
---|---|
Format: | article |
Language: | EN |
Published: |
Wiley
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/c979b079617a4b38afa6c44a5b637f4c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Progesterone Aggravates Lung Fibrosis in a Mouse Model of Systemic Sclerosis
by: Fatemeh Vafashoar, et al.
Published: (2021) -
Сatalase antibodies in patients with systemic scleroderma as a diagnostic and prognostic marker of the disease
by: O. I. Emelyanova, et al.
Published: (2021) -
DIAGNOSTIC VALUE OF CERULOPLASMIN IN SYSTEMIC SCLERODERMA
by: O. I. Emelyanova, et al.
Published: (2019) -
PDGF Promotes Dermal Fibroblast Activation via a Novel Mechanism Mediated by Signaling Through MCHR1
by: Naoko Takamura, et al.
Published: (2021) -
Successful Milk Oral Immunotherapy Promotes Generation of Casein-Specific CD137+ FOXP3+ Regulatory T Cells Detectable in Peripheral Blood
by: Yi Zhang, et al.
Published: (2021)